Institution statistics

DEUTSCHES KREBSFORSCHUNGSZENTRUM - Germany 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:300-400
Project Leadership Index:82
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:64
Partner Constancy:58
Project Leadership Index:47
Diversity Index:47
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:61
Networking Rank (Reputation):300-400
Networking Rank (Reputation):300-400
Partner Constancy:46
Project Leadership Index:75
Diversity Index:37
2011
Criterium:Position:
Overall Score:600-700
Total Project Funding:400-500
Total Project Funding per Partner:400-500
Total Number of Projects:300-400
Networking Rank (Reputation):400-500
Partner Constancy:700-800
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:400-500
Total Project Funding:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):200-300
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:300-400
2008
Criterium:Position:
Overall Score:300-400
Total Project Funding:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):200-300
Partner Constancy:200-300
Project Leadership Index:300-400
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:900-1000
Total Project Funding:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):400-500
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2017-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 126
As coordinator: 6
As participant: 104
Sole participant: 16
Coordinator / Participant Ratio: 0.06*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 7.370.000 4.899.800 5.071.293 1 3
2016 1.738.955 11.293.830 3.577.666 2 4
2015 2.168.794 38.787.645 6.599.362 2 8
2014 261.969 0 261.969 2
2013 6.195.747 35.879.301 5.378.404 3 7
2012 336.754 46.735.876 9.984.848 2 10
2011 8.098.428 25.638.979 2.526.368 3 5
2010 0 44.806.245 5.170.661 6
2009 100.000 42.684.009 5.275.488 1 8
2008 0 51.432.041 3.104.084 8
2007 0 5.914.351 455.959 2
2006 0 88.414.466 4.416.755 12
2005 6.644.656 70.077.480 7.339.590 4 13
2004 2.574.811 97.165.051 8.075.006 2 14
2003 0 2.200.303 275.038 2
2001 0 328.901 32.890 1
2000 0 2.625.000 238.636 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE24
KAROLINSKA INSTITUTE23
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE18
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE14
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE13
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD13
EUROPEAN MOLECULAR BIOLOGY LABORATORY12
UNIVERSITY COLLEGE LONDON12
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER11
LUNDS UNIVERSITET10
MEDICAL RESEARCH COUNCIL10
CHARITE UNIVERSITAETSMEDIZIN BERLIN9
UNIVERSITAETSKLINIKUM HEIDELBERG8
INSTITUT CURIE7
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI7
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV7
THE UNIVERSITY OF MANCHESTER7
UNIVERSITY OF COPENHAGEN7
DANISH CANCER SOCIETY6
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR6
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III6
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT6
INSTITUT PASTEUR6
KING'S COLLEGE LONDON6
LEIDEN UNIVERSITY MEDICAL CENTER6
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN6
MEDIZINISCHE UNIVERSITAET WIEN6
UNIVERSITAET ZUERICH6
UNIVERSITY OF BIRMINGHAM6
UNIVERSITY OF HELSINKI6
VTT TECHNICAL RESEARCH CENTRE OF FINLAND6
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS5
GENETHON5
KATHOLIEKE UNIVERSITEIT LEUVEN5
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS5
RUPRECHT KARLS UNIVERSITAET HEIDELBERG5
UNIVERSITAT AUTONOMA DE BARCELONA5
UNIVERSITY OF AARHUS5
UNIVERSITY OF LEEDS5
VRIJE UNIVERSITEIT BRUSSEL5
ACIES SAS4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS4
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG4
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE4
GATC BIOTECH4
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE4
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE4
INSTITUT GUSTAVE ROUSSY4
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL4
ISTITUTO EUROPEO DI ONCOLOGIA4
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN4
MEDIZINISCHE HOCHSCHULE HANNOVER4
MEDIZINISCHE UNIVERSITAET INNSBRUCK4
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS4
THE UNIVERSITY OF LIVERPOOL4
THE UNIVERSITY OF WARWICK4
UNIVERSITE DE LAUSANNE4
UNIVERSITEIT GENT4
UNIVERSITEIT MAASTRICHT4
UNIVERSITEIT UTRECHT4
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN4
UNIVERSITY OF TURKU4
UPPSALA UNIVERSITET4
ACADEMISCH ZIEKENHUIS GRONINGEN3
ALBERT LUDWIGS UNIVERSITAET FREIBURG3
ARTTIC3
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING3
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC3
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER3
EBERHARDKARLSUNIVERSITAET TUEBINGEN3
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN3
FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW3
FOUNDATION FOR GENOMICS & POPULATION HEALTH3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
FUNDACIO CENTRE DE REGULACIO GENOMICA3
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT3
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG3
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON3
INSERM TRANSFERT3
INSTITUT CATALA D'ONCOLOGIA3
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI3
ISTITUTO SUPERIORE DI SANITA3
LUDWIG INSTITUT FUER KREBSFORSCHUNG3
MOLECULAR MEDICINE3
NATIONAL UNIVERSITY OF IRELAND GALWAY3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
QUEENSLAND INSTITUTE OF MEDICAL RESEARCH3
STICHTING VU3
TECHNISCHE UNIVERSITAET MUENCHEN3
THE BABRAHAM INSTITUTE3
THE HEBREW UNIVERSITY OF JERUSALEM3
UNIVERSIDAD DE NAVARRA3
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA3
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II3
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA3
Constancy:

Total number of partners:1440

Partner loyalty:
Frequent Partner: (> 2 projects): 578
Rare Partner: 862

Frequent / Rare Partner Ratio: 0.67

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES78
RTD HORIZONTAL TOPICS36
SOCIAL AND ECONOMIC CONCERNS23
AGRICULTURE AND MARINE RESOURC5
INDUSTRY AND TECHNOLOGY4
PHYSICAL AND EXACT SCIENCES1
PROTECTING MAN AND HIS ENVIRON1

Project overview:

Start dateProjectacronymrolefundingpartners
2017-09-01Centre of Excellence in Digital Health and Personalised Medicine Clinnovaparticipant399.8005
2017-07-01Endogenous barcoding for in vivo fate mapping of lineage development in the blood and immune system BARCODED-CELLTRACINGparticipant2.500.0001
2017-05-18ITCC Pediatric Preclinical POC Platform (ITCC-P4) ITCC-P4coordinator7.370.00015
2017-03-01Regulation of Cellular Growth and Metabolism by C18:0 C18Signalingparticipant2.000.0001
2016-11-07Deciphering the machinery involved in stability of the transcription factor HOXA9. HOXA9 degradomecoordinator239.8611
2016-06-01Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers EVI1inCancercoordinator1.499.0941
2016-01-01Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. HEP-CARparticipant5.698.31010
2016-01-01RNA EDITING IN HEALTH AND DISEASE RNAEDITparticipant2.270.0003
2016-01-01Towards outstanding research and training in tumour biology at IMM ReTuBiparticipant999.9753
2016-01-01European Regulatory Science on Tobacco:Policy implementation to reduce lung diseases EUREST-PLUSparticipant2.325.54513
2015-10-01implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC ADOPT BBMRI-ERICparticipant4.949.44919
2015-09-01Statistical multi-Omics UNDerstanding of Patient Samples SOUNDparticipant2.953.06313
2015-09-01Coordinated Research Infrastructures Building Enduring Life-science services CORBELparticipant14.837.80035
2015-09-01Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes B-CASTparticipant5.983.35613
2015-07-01Regulating the immune regulators: targeting adaptive immune control REGiREGparticipant1.955.0001
2015-07-01Computational Biophotonics for Endoscopic Cancer Diagnosis and Therapy COMBIOSCOPYparticipant1.499.6993
2015-06-01Dissection of tumor heterogeneity in vivo CancerHeterocoordinator2.000.0001
2015-01-01The RANK-Axis in Breast Cancer: A comprehensive prospective evaluation of promising novel biomarkers RANKL_OPGcoordinator168.7941
2015-01-01Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome EpiPredictparticipant2.797.6978
2015-01-01Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells IMMUNOSHAPEparticipant3.811.58115
2014-09-01Identifying and characterising transmembrane transporters of tryptophan and kynurenine in normal and cancerous brain tissue KP TRANSPORTcoordinator161.9691
2014-04-01Mechanisms of Mismatch repair inactivation and identification of genes suppressing mutations IMMRcoordinator100.0001
2013-11-01Immunostimulatory Agonist antibodies for Cancer Therapy IACTcoordinator5.995.74710
2013-10-01Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors REQUITEparticipant5.997.40815
2013-09-01T-cell based immunotherapy in pancreatic cancer - basic concepts and pre-clinical development TIPC_TIL_IPcoordinator100.0001
2013-06-01Analysis of Tenascin C function in breast cancer metastasis to bone BONEMETTNCcoordinator100.0001
2013-05-01Quantitative T cell Immunology QUANTIparticipant4.012.57012
2013-05-01Towards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancer SUPERSISTparticipant5.999.9975
2013-05-01Deciphering the regulatory T cell repertoire: towards biomarkers and biotherapies for autoimmune diseases TRIPODparticipant2.500.0002
2013-02-01PIVOTAL ASSESSMENT OF THE EFFECTS OF BIOACTIVES ON HEALTH AND WELLBEING. FROM HUMAN GENOMA TO FOOD INDUSTRY - PATHWAY PATHWAY-27participant5.999.23125
2013-01-01Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action EUROFANCOLENparticipant5.380.17011
2013-01-01Early warning signals of ageing in human stem cells and age-related disorders SYSTEMAGEparticipant5.989.9259
2012-12-01Systems medicine of chronic inflammatory bowel disease SYSMEDIBDparticipant11.999.99812
2012-12-01Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) NET4CGDparticipant5.999.60711
2012-10-01Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes DIABIL-2participant5.900.0006
2012-08-01Infrastructure for Systems Biology - Europe ISBEparticipant4.745.71823
2012-08-01Global Mapping of Synthetic Genetic Interactions in Drosophila SYNGENEparticipant2.500.0001
2012-06-01Generating self-antigen diversity in the thymus: from gene expression patterns in single cells to the system level, an integrative approach Self-toleranceparticipant2.014.5601
2012-05-01Unlocking the potential of ultra-high-field MRI through manipulation of radiofrequency excitation fields in human tissue MRexciteparticipant2.099.9962
2012-03-07Regulation of Argonaute-2 and miRNA-dependent mRNA decay in response to oxidative stress and DNA damage mirnaAGOddrcoordinator167.3901
2012-02-01Defining the Impact of Chromosome Instability in Tumor Initiation, Maintenance and Relapse MADCINparticipant1.500.0002
2012-01-01Target binders TARGETBINDERparticipant3.988.73010
2012-01-01EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations EPIC-CVDparticipant5.987.26630
2012-01-01The DNA damage response pathway in MYCN amplified neuroblastoma DDR-MYCN-NBcoordinator169.3631
2011-12-01Development of a therapeutic HPV vaccine via target epitope identification by mass spectrometry THERAVACcoordinator100.0001
2011-10-01Recruitment and activation of brown adipocytes as preventive and curative therapy for type 2 diabetes DIABATcoordinator5.999.99821
2011-09-01Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe HPV-AHEADparticipant2.999.94611
2011-04-01EU and North African Migrants: Health and Health Systems EUNAMcoordinator1.998.4308
2011-02-01A SOCIAL COLLABORATIVE WORKING SPACE SEMANTICALLY INTERLINKING BIOMEDICAL RESEARCHERS, KNOWLEDGE AND DATA FOR THE DESIGN AND EXECUTION OF IN-SILICO MODELS AND EXPERIMENTS IN CANCER CHEMOPREVENTION GRANATUMparticipant2.995.0007
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428

overview shows latest 50 from 126 projects (2000-01-01 - 2017-12-31)
A full list of projects can be found here:

Alias institution names:
  • DEUTSCHES KREBSFORSCHUNGSZENTRUM

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: